Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125841552 | 12584155 | 2 | F | 20160607 | 20160725 | 20160722 | 20160728 | EXP | JP-AMGEN-JPNSP2016088140 | AMGEN | 72.00 | YR | E | F | Y | 0.00000 | 20160728 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125841552 | 12584155 | 1 | PS | G-LASTA | PEGFILGRASTIM | 1 | Subcutaneous | 3.6 MG, UNK | U | 125031 | 3.6 | MG | SOLUTION FOR INJECTION | ||||||
| 125841552 | 12584155 | 2 | SS | ONETAXOTERE | DOCETAXEL | 1 | Intravenous drip | 120 MG, UNK | 0 | 120 | MG | INJECTION | |||||||
| 125841552 | 12584155 | 3 | SS | ONETAXOTERE | DOCETAXEL | 1 | Intravenous drip | 120 MG, UNK | 0 | 120 | MG | INJECTION | |||||||
| 125841552 | 12584155 | 4 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 960 MG, UNK | 0 | 960 | MG | ||||||||
| 125841552 | 12584155 | 5 | SS | ENDOXAN | CYCLOPHOSPHAMIDE | 1 | Intravenous drip | 960 MG, UNK | 0 | 960 | MG | ||||||||
| 125841552 | 12584155 | 6 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous drip | 75 MG, SINGLE | 0 | 75 | MG | INJECTION | |||||||
| 125841552 | 12584155 | 7 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Intravenous drip | 075 MG, SINGLE | 0 | .75 | MG | INJECTION | |||||||
| 125841552 | 12584155 | 8 | C | DEXART | DEXAMETHASONE SODIUM PHOSPHATE | 1 | Intravenous drip | 3.3 MG, BID | 0 | 3.3 | MG | INJECTION | BID | ||||||
| 125841552 | 12584155 | 9 | C | DEXART | DEXAMETHASONE SODIUM PHOSPHATE | 1 | Intravenous drip | 3.3 MG, BID | 0 | 3.3 | MG | INJECTION | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125841552 | 12584155 | 1 | Colony stimulating factor prophylaxis |
| 125841552 | 12584155 | 2 | Breast cancer |
| 125841552 | 12584155 | 4 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125841552 | 12584155 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125841552 | 12584155 | Blood uric acid increased | |
| 125841552 | 12584155 | Platelet count decreased | |
| 125841552 | 12584155 | Urinary tract infection | |
| 125841552 | 12584155 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125841552 | 12584155 | 1 | 20160530 | 0 | ||
| 125841552 | 12584155 | 2 | 20160506 | 0 | ||
| 125841552 | 12584155 | 3 | 20160527 | 0 | ||
| 125841552 | 12584155 | 4 | 20160506 | 0 | ||
| 125841552 | 12584155 | 5 | 20160527 | 0 | ||
| 125841552 | 12584155 | 6 | 20160506 | 0 | ||
| 125841552 | 12584155 | 7 | 20160527 | 0 | ||
| 125841552 | 12584155 | 8 | 20160506 | 0 | ||
| 125841552 | 12584155 | 9 | 20160527 | 0 |